Skip to main content
Premium Trial:

Request an Annual Quote

Olink Signature Q100

Olink is now taking orders for the Olink Signature Q100 benchtop system for protein biomarker analysis. The system is designed for readout of Olink protein biomarker panels, which previously had been exclusively carried out using Fluidigm's BioMark instrument. The Olink Signature Q100, which will be manufactured by Fluidigm for Olink, is a dedicated platform that will enable researchers to run Olink kits more easily using as little as 1 uL of plasma or serum. The platform supports Olink Target 96 panels, which enable the relative quantification of 92 selected proteins across 90 samples simultaneously; Olink Target 48 Cytokine panels, which enable the analysis of 45 selected proteins across 40 samples simultaneously with optional absolute quantification of protein levels; and Olink Focus custom panels for up to 21 customer-selected proteins.

The company said that customers can pre-order Olink Signature as of June 2 with delivery expected in the fourth quarter of 2021.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.